ESC 365 - Glycosylated haemoglobin predicts mortality in patients with heart failure and unknown diabetes - insights from the Swedish heart failure registry (SwedeHF)

Back

ESC Premium Access

Glycosylated haemoglobin predicts mortality in patients with heart failure and unknown diabetes - insights from the Swedish heart failure registry (SwedeHF)

Session: Poster session 4 - Fighting againts diabetes epidemic

Topic: Diabetes, dysglycaemia and metabolic syndrome

Speaker: Doctor I. Johansson (Stockholm, SE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Isabelle Johansson

Karolinska Institute, Stockholm (Sweden)

2 presentations

0 follower

16 more presentations in this session

Angiopoietin-like 2 is associated with increased risk of death in diabetic patients

Speaker: Doctor B. Gellen (Poitiers, FR)

Access

Abstract

Epicardial adipose tissue and cardiovascular disease in type 2 diabetes

Speaker: Doctor R. Christensen (Copenhagen, DK)

Access

Abstract

Slides

Arterial stiffness as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Speaker: Mr S. Sharif (Utrecht, NL)

Access

Abstract

Slides

Plasma dehydroepiandrosterone levels are inversely associated with the risk of type 2 diabetes: the Rotterdam Study

Speaker: Miss A. Brahimaj (Rotterdam, NL)

Access

Abstract

Slides

Are the LDL-cholesterol targets from the ESC/EASD guidelines achievable in diabetic patients?

Speaker: Doctor J. Dillinger (Paris, FR)

Access

Abstract

Slides

Access the full session

Poster session 4 - Fighting againts diabetes epidemic

Speakers: Doctor I. Johansson, Doctor B. Gellen, Doctor R. Christensen, Mr S. Sharif, Miss A. Brahimaj...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources